VitroGel Hydrogel Matrix
Optimized formulation of multi-functional ligands and concentration to support a wide range of cell types for different applications.
Product Description
„Just Add Cells"– The hydrogel matrix is ready to mix with cell suspension directly. There is no additional adjustment needed.
- 3D and 2D cell culture
- Ready-to-use
- Xeno-free
- Injectable
- Biocompatible
- Multi-functional
- Work at room temperature
- Easy cell harvesting - 20 min protocol
VitroGel Hydrogel Matrix closely mimics the natural extracellular matrix (ECM) environment to make cells feel more like at home. The hydrogel is room temperature stable, has a neutral pH, transparent, permeable and compatible with different imaging systems. The solution transforms into a hydrogel matrix by simply mixing with the cell culture medium. Cells cultured in this system can be easily harvested out with our VitroGel Cell Recovery Solution.
VitroGel xeno-free hydrogels are excellent for injection and a superior alternative to the animal-based extracellular matrix or plant-based hydrogel for xenograft, targeted delivery, control release, and cell therapy for tissue engineering.
This user-friendly functional hydrogel creates an excellent balance of simplicity and versatility.
Applications
- 3D cell model
- 2D hydrogel coating
- Co-culture
- Invasion assay
- 3D migration
- Animal injection
- Control release
- FRESH bioprinting
- High throughput screening
3D cell culture process in 20 min
Learn how to use the VitroGel® Systems with Demonstration Videos.
Product Citations
- (2023) Celecoxib, a Non-Steroidal Anti-Inflammatory Drug, Exerts a Toxic Effect on Human Melanoma Cells Grown as 2D and 3D Cell Cultures Life
- (2023) Zebrafish Patient-Derived Xenograft Model as a Preclinical Platform for Uveal Melanoma Drug Discovery Pharmaceuticals
- Hong, E., Barczak, W., Park, S., Heo, J. S., Ooshima, A., Munro, S., Hong, C. P., Park, J., An, H., Park, J. O., Park, S. H., La Thangue, N. B., & Kim, S.-J. (2023) Combination treatment of T1-44, a PRMT5 inhibitor with Vactosertib, an inhibitor of TGF-β signaling, inhibits invasion and prolongs survival in a mouse model of pancreatic tumors Cell Death & Disease
- Marcel Janis Beha, Joo-Chan Kim, San Hae Im, Yunsu Kim, Seungju Yang, Juhee Lee, Yu Ri Nam, Haeshin Lee, Hee-Sung Park, Hyun Jung Chung (2023) Bioorthogonal CRISPR/Cas9-Drug Conjugate: A Combinatorial Nanomedicine Platform Advanced Science
- Scarlett Zeiringer, Laura Wiltschko, Christina Glader, Martin Reiser, Markus Absenger-Novak, Eleonore Fröhlich, and Eva Roblegg (2023) Development and Characterization of an In Vitro Intestinal Model Including Extracellular Matrix and Macrovascular Endothelium Molecular Pharmaceutics
